Our results suggest that Enz has a major role in downregulating the u-PAR through Sp1/Sp3 and c-Jun(AP-1), besides HIF1α and VEGFC that are implicated in tumour growth and metastasis, in parallel to upregulating tumour-suppressors relevant for NSCLC. Here, SP1 is linked to neoplasm.